Matthew M. Walsh, See Remarks at Catalent, Inc. (CTLT), sold 84,717 shares at $31.18 ($2.6M) on 2015-07-27, disclosed to the SEC on 2015-07-29.
Scheduled sale ($2.6M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.50 | 12,831 | $391K | 15.0% |
| 2 | $30.50 | 13,574 | $414K | 15.9% |
| 3 | $30.50 | 31,140 | $950K | 36.5% |
| 4 | $31.18 | 5,116 | $160K | 6.1% |
| 5 | $31.18 | 6,436 | $201K | 7.7% |
| 6 | $31.18 | 15,620 |
| $487K |
| 18.7% |
| Total | $30.72 avg | 84,717 | $2.6M | 100% |
| Filing → |
| CERT | BUY | 2020-12-16 | $115K | — | Filing → |
| AGN | BUY | 2018-11-19 | $157K | — | Filing → |
| AGN | BUY | 2018-03-08 | $154K | — | Filing → |